Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Certican (Everolimus) for CMV Disease in Renal Transplant
NCT00828503Phase 2Unknown
- Start
- Dec 2008
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in cytomegalovirus disease (CMV). Status: unknown.
02
Drugs
everolimus
03
Conditions
cytomegalovirus disease (CMV)
Beyond the preview
Go deeper on NCT00828503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00828503.